Pfizer’s giant R&D effort is getting more efficient, but there’s still a ways to go. That’s the diagnosis from CEO Jeff Kindler himself, who sat down with Bloomberg for a video interview that’s online today — exactly two years after Kindler got the top job at the company.
“There absolutely need to be more efficiencies in [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment